FMT-68976-53006
2 vaccinations
5 coded responses
23 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 741 / OK
- Registered
- 2021-03-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-26
Registered in v-safe
-
2021-03-26
Dose 1 — Pfizer-BioNTech
- 2021-03-26
-
2021-03-27
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: Good · Site: PainFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-28
Survey response — days 1–6 daily, dose 1MedDRA: Oesophageal pain — Feeling: Good · Fatigue or tirednessFree text: Just severe reflux pain for about 30 hoursMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
-
2021-04-02
Survey response — day 7, dose 1MedDRA: Fatigue — Feeling: Good · Fatigue or tirednessFree text: Fatigue is beginning to go awayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-09
-
2021-04-16
Dose 2 — Pfizer-BioNTech
-
2021-04-16
Survey response — day 0, dose 2MedDRA: Unevaluable event — Feeling: GoodFree text: I just received my 2nd dose one hour agoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-19
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-20
- 2021-04-21
- 2021-04-22
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-05-21
- 2021-05-28
- 2021-07-16
-
2022-04-16
Survey response — 12 months, dose 2MedDRA: Adverse drug reaction, Areflexia, Condition aggravated, Hypoaesthesia, Medical counselling, Muscle spasms, Pain in extremity, Pre-existing disease, Reaction to previous exposure to any vaccine — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Bilateral foot pain with spasms and numbness. Feels as though I'm walking on marbles. Scheduled with a pain specialist soon. · Healthcare visit (other): It started after my first Pfizer shot, worsened by my second shot, was worse after my booster. Has an EMG, saw a podiatrist, Lyrica increased my BP, and heart rate way to much. My internist said I am absent of bilateral foot reflexes. I am scheduled.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-16
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2022-04-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-26 | Pfizer-BioNTech | |
| 2 | 2021-04-16 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): No
Systemic reaction (other): Just severe reflux pain for about 30 hours
Release 6 — day 7, dose 1
Systemic reaction (other): Fatigue is beginning to go away
Release 7 — day 0, dose 2
Systemic reaction (other): I just received my 2nd dose one hour ago
Release 11 — 12 months, dose 2
Symptoms: Bilateral foot pain with spasms and numbness. Feels as though I'm walking on marbles. Scheduled with a pain specialist soon.
Healthcare visit (other): It started after my first Pfizer shot, worsened by my second shot, was worse after my booster. Has an EMG, saw a podiatrist, Lyrica increased my BP, and heart rate way to much. My internist said I am absent of bilateral foot reflexes. I am scheduled. cut off by CDC
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Adverse drug reaction | · | · | ✓ |
| HCVO | Areflexia | · | · | ✓ |
| HCVO | Condition aggravated | · | · | ✓ |
| HCVO | Medical counselling | · | · | ✓ |
| HCVO | Pre-existing disease | · | · | ✓ |
| HCVO | Reaction to previous exposure to any vaccine | · | · | ✓ |
| SD | Hypoaesthesia | · | · | ✓ |
| SD | Muscle spasms | · | · | ✓ |
| SD | Pain in extremity | · | · | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
| SRO | Oesophageal pain | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release